105 Results

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Horwitz
    Horwitz
  4. Goldberg
    Goldberg
  5. Jakubowski
    Jakubowski
  6. Dahi
    Dahi
  7. Papanicolaou
    Papanicolaou
  8. Tallman
    Tallman
  9. Stein
    Stein
  10. Zelenetz
    Zelenetz

Groups

  1. Department of Medicine (84)
  2. Hematologic Malignancies, Division of (79)
  3. Center for Hematologic Malignancies (73)
  4. Bone Marrow Transplant (31)
  5. Adult Leukemia (25)
  6. Lymphoma (22)
  7. Survivorship Research (20)
  8. Division of Subspecialty Medicine (15)
  9. Population Sciences Research Program (14)
  10. Epidemiology and Biostatistics (13)
  1. "allogeneic stem cell transplantation"
Formats
  1. Journal Article (86)
  2. Research Letter (8)
  3. Editorial (4)
  4. Review (4)
  5. Guidelines (2)
  6. Book Section (1)
Groups
  1. Department of Medicine (84)
  2. Hematologic Malignancies, Division of (79)
  3. Center for Hematologic Malignancies (73)
  4. Bone Marrow Transplant (31)
  5. Adult Leukemia (25)
  6. Lymphoma (22)

More Groups

People
  1. Miguel-Angel Perales (16)
  2. Sergio Giralt (14)
  3. Steven Horwitz (10)
  4. Aaron Goldberg (9)
  5. Ann Jakubowski (8)
  6. Martin Tallman (8)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (7)
  5. 2021 (5)
  6. 2020 (9)

More Years

Publications
  1. Leukemia and Lymphoma (14)
  2. Biology of Blood and Marrow Transplantation (12)
  3. Bone Marrow Transplantation (7)
  4. Clinical Advances in Hematology & Oncology (6)
  5. Blood (5)
  6. Haematologica (5)

More Publications

Publishers
  1. Elsevier Inc. (20)
  2. Taylor & Francis Group (14)
  3. Nature Publishing Group (13)
  4. American Society of Hematology (7)
  5. Millennium Medical Publishing, Inc (6)
  6. Ferrata Storti Foundation (5)

More Publishers

Results (105)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
    Research Letter

    Badar, T.; Nanaa, A.; Atallah, E.; Shallis, R. M.; Guilherme, S. D. C. C.; Goldberg, A. D.; Saliba, A. N.; Patel, A.; Bewersdorf, J. P.; DuVall, A. S.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab
    Research Letter

    Stuver, R.; Vardhana, S. A.; Bedmutha, A.; Chan, K. K.; Mirtcheva-Trocheva, R.; Nosov, A.; Schöder, H.; Moskowitz, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
    Journal Article

    Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
    Journal Article

    Badar, T.; Atallah, E.; Shallis, R.; Saliba, A. N.; Patel, A.; Bewersdorf, J. P.; Grenet, J.; Stahl, M.; Duvall, A.; Burkart, M.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Prediction of nonrelapse mortality in patients with acute myeloid leukemia and acute lymphoblastic leukemia receiving allogeneic stem cell transplantation with posttransplantation cyclophosphamide-based graft versus host disease prophylaxis
    Journal Article

    Hermans, S. J. F.; Versluis, J.; Labopin, M.; Giebel, S.; van Norden, Y.; Moiseev, I.; Blaise, D.; Díez Martín, J. L.; Meijer, E.; Rovira, M.; more...
    HemaSphere (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma
    Research Letter

    Gardenswartz, A.; Mehta, B.; El-Mallawany, N. K.; van de Ven, C.; Hochberg, J.; Flower, A.; Morris, E.; Harrison, L.; Chu, Y.; Basso, J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation
    Journal Article

    Taranto, E.; Redd, R.; Jeter, E.; McHugh, K.; Crombie, J. L.; Fisher, D. C.; Jacobsen, E.; Jacobson, C. A.; Kim, A. I.; LaCasce, A. S.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study
    Journal Article

    Shah, B. D.; Ghobadi, A.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Cassaday, R. D.; Leguay, T.; Bishop, M. R.; Topp, M. S.; Tzachanis, D.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Investigational venetoclax combination therapy in acute myeloid leukemia - A systematic review and meta-analysis
    Research Letter

    Shimony, S.; Rozental, A.; Bewersdorf, J. P.; Goldberg, A. D.; Stein, E. M.; Grimshaw, A. A.; Stone, R. M.; DeAngelo, D. J.; Wolach, O.; Stahl, M.
    Haematologica (2022)

    Fulltext@MSK | Save